"In het WKZ zien we elke dag hoe bijzonder kinderen zijn. Ieder kind zit anders in elkaar, heeft eigen behoeften en reageert anders op behandelingen. Ieder kind verdient maatwerk, afgestemd op zijn of haar situatie. Samen met het kind en zijn of haar ouders willen we tot de beste zorg komen. Continu onderzoek hoort daar ook bij, waardoor we altijd aan het leren zijn. We zijn er ook voor aanstaande moeders, al tijdens de zwangerschap. Met alle kennis en voorzieningen rond zwangerschap en bevallen zijn we gespecialiseerd in de zorg voor moeders en hun pasgeboren baby’s."

During the past decade, UMC Utrecht, Wilhelmina kinderziekenhuis conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UMC Utrecht, Wilhelmina kinderziekenhuis" #1 sponsor was "Eli Lilly and Company" with 1 trials, followed by "Erasmus Medical Center" with 1 trials sponsored, "Jazz Pharmaceuticals" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "UMC Utrecht" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UMC Utrecht, Wilhelmina kinderziekenhuis" #1 collaborator was "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "MeMed Diagnostics Ltd." with 1 trials as a collaborator, "Nederlands Neonataal Netwerk (N3), the Netherlands" with 1 trials as a collaborator and "Universitaire Ziekenhuizen KU Leuven" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "UMC Utrecht, Wilhelmina kinderziekenhuis" are "Apnea of Prematurity" (1 trials), "Arthritis Juvenile Idiopathic" (1 trials), "Enthesitis Related Arthritis" (1 trials), "Juvenile Psoriatic Arthritis" (1 trials) and "Lower Respiratory Tract Infection" (1 trials). Many other conditions were trialed in "UMC Utrecht, Wilhelmina kinderziekenhuis" in a lesser frequency.

Most popular intervention types in "UMC Utrecht, Wilhelmina kinderziekenhuis" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Adalimumab" (1 trials), "Doxapram" (1 trials), "GWP42003-P" (1 trials) and "In double-blind phase: treatment with tofacitinib or placebo in 1:1 ratio" (1 trials). Other intervention names were less common.

The vast majority of trials in "UMC Utrecht, Wilhelmina kinderziekenhuis" are 5 trials for "All" genders.

Currently, there are NaN active trials in "UMC Utrecht, Wilhelmina kinderziekenhuis". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UMC Utrecht, Wilhelmina kinderziekenhuis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UMC Utrecht, Wilhelmina kinderziekenhuis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".